Adam Sragovicz - 01 Dec 2023 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
Chief Financial Officer
Signature
/s/ Adam Sragovicz
Issuer symbol
CDT
Transactions as of
01 Dec 2023
Transactions value $
$0
Form type
4
Filing time
05 Dec 2023, 17:20:16 UTC
Previous filing
04 Jan 2023
Next filing
15 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDT Restricted Stock Units Award +74.5K 74.5K 01 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units were granted with a vesting schedule of 33.3% on each of the first three anniversaries of the vesting commencement date, which is September 22, 2023.